Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 22, 2008

View Archived Issues

Adoptive transfer of T cells loaded with oncolytic virus effective in eliminating cancer metastasis

Endothelial progenitor cells regulate the angiogenic switch in lung metastasis model

Promising preclinical results of novel broadly neutralizing antibodies against HCV infection

Eisai granted early termination of statutory waiting period in acquisition of MGI

Novel therapeutic agents for hematologic disorders reported in recent patent literature

Adherex initiates phase IIb clinical trial of ADH-1 for melanoma

Senexis secures new funding to develop innovative compounds for AD

Angiotech and Symphony enter licensing agreement for PEG-based biomaterials

Primary endpoint met in phase II trial of 2PX for osteoarthritis

Peptimmune completes first close of series D preferred stock offering

Genaera initiates phase I trial of trodusquemine in overweight and obese diabetic patients

Preclinical characterization of aripiprazole shows uniqueness of D2 partial agonists

Cleveland BioLabs' Protectan CBLB-502 not selected for defense contract award

Diamyd submits application to initiate phase III studies of Diamyd in Sweden

Decreased VLDLR expression may be a biomarker for schizophrenia

Cerepro phase III trial results expected in July 2008

FDA committee to consider two injectable antibiotics from Theravance and J&J

GSK will not option XL-784 for further development

Recent Novartis patent discloses novel antiasthmatic agents

Schering-Plough and Shionogi launch Claritin dry syrup 1%

Motilin receptor agonists described in recent GSK patent

Roche and Ventana sign definitive merger agreement

Promising results for GW cannabinoid treatments for diabetes and metabolic disorders

Progress from Arpida's pivotal phase III trial of TLT treatment in onychomycosis

New treatment option for psoriasis imparted in recent Nippon Shinyaku patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...